Anika Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +900.0% | +15.8% | -2.9% | +21.0% | -30.8% | +16.6% | +16.8% | +71.8% | +12.7% | -10.0% | +14.9% | +16.1% | +12.2% | +38.4% | +16.6% | +10.2% | +5.2% | +40.6% | -11.9% | +11.2% | +9.7% | -6.9% | +8.6% | +13.8% | +13.3% | +5.7% | -22.7% | -0.7% | -5.9% | |
| – | +528.6% | +18.2% | +1.9% | +63.6% | -5.1% | -1.5% | -1.3% | +24.3% | +12.0% | -0.2% | +6.9% | +11.0% | +3.7% | +74.3% | +12.4% | +8.2% | -21.5% | -8.1% | +0.6% | +14.1% | +13.9% | +14.3% | -8.1% | +113.7% | +5.6% | -3.4% | -38.9% | +14.8% | +11.6% | |
| – | +1,420.0% | +14.5% | -5.7% | -6.6% | -59.8% | +64.7% | +45.7% | +123.2% | +13.2% | -15.9% | +20.5% | +19.2% | +17.1% | +19.9% | +19.7% | +11.5% | +23.5% | +61.8% | -15.0% | +10.3% | +8.4% | -13.7% | +15.6% | -19.6% | +20.2% | +12.8% | -11.8% | -7.9% | -16.0% | |
| – | +25.0% | +0.0% | +110.0% | -22.4% | +31.3% | -8.2% | -33.9% | +57.5% | +15.8% | -23.6% | +20.7% | +69.5% | +10.6% | -16.0% | -10.3% | -12.7% | +31.0% | +15.4% | +10.3% | +19.4% | +75.1% | -3.2% | -8.4% | +40.6% | +16.6% | +3.1% | -22.8% | +17.4% | +0.9% | |
| – | +40.0% | +28.6% | +11.1% | +39.6% | +48.4% | -28.8% | -4.9% | +43.5% | -10.5% | +23.5% | +19.7% | +37.1% | -3.8% | +64.2% | +3.1% | -17.5% | -12.2% | +16.5% | -1.6% | +21.5% | +19.6% | +59.4% | +1.8% | +71.9% | -11.8% | +60.0% | +16.2% | -43.6% | -11.6% | |
| – | +37.5% | +25.0% | +50.9% | +4.2% | +21.4% | -20.4% | -18.5% | +48.9% | +0.1% | +1.5% | +20.1% | +48.6% | +2.0% | +29.2% | -0.7% | -16.3% | -0.6% | +16.1% | +2.6% | +20.7% | +40.3% | +30.3% | -1.7% | +88.6% | -17.5% | +40.6% | -27.7% | -0.7% | -7.7% | |
| – | – | +0.0% | -103.1% | – | – | – | – | +973.6% | +33.9% | -36.5% | +21.4% | -35.8% | +32.2% | +34.9% | +85.3% | +41.2% | +65.4% | +88.4% | -21.7% | +5.1% | -9.6% | -52.4% | +57.5% | -182.7% | – | -841.9% | – | -704.4% | – | |
| – | +400.0% | +400.0% | -92.0% | +486.4% | -43.5% | -63.8% | -39.9% | +170.1% | +219.0% | +69.3% | 0.0% | -76.3% | +778.3% | -95.6% | -6.3% | +2,786.0% | -97.6% | -54.3% | +106.4% | +119.2% | +79.8% | +208.2% | +439.4% | -89.8% | -76.5% | +247.9% | +253.5% | +1.1% | -25.4% | |
| – | – | +29.4% | -102.3% | – | -3,661.4% | – | – | +817.1% | +44.5% | -23.1% | +15.4% | -45.6% | +16.7% | +33.2% | +87.7% | +41.7% | +66.3% | +89.4% | -21.5% | +5.4% | -9.2% | -49.8% | +55.6% | -179.2% | – | -872.4% | – | -187.6% | – | |
| – | +0.0% | +0.0% | +2,100.0% | -99.3% | -43.0% | -45.0% | -1,861.1% | – | – | -25.0% | -9.3% | -58.7% | +66.5% | +65.9% | +75.7% | +46.1% | +53.2% | +94.8% | -24.5% | +4.7% | -21.5% | -68.8% | +99.1% | -152.0% | – | – | – | -8.1% | -88.9% | |
| – | – | +30.3% | -158.1% | – | -3,993.7% | – | – | +1,253.1% | -47.3% | -21.9% | +31.1% | -39.9% | +1.6% | +17.0% | +96.2% | +38.9% | +75.0% | +86.2% | -19.7% | +5.8% | -2.2% | -41.2% | +45.2% | -188.2% | – | -459.4% | – | – | – | |
| – | – | -3.6% | -67.4% | -80.5% | -2,981.4% | – | – | +807.3% | -38.0% | -35.5% | +27.4% | -23.6% | +97.6% | -2.9% | +65.5% | +49.0% | +19.6% | +106.5% | -21.5% | +4.7% | -8.0% | -44.7% | +45.5% | -102.5% | – | – | – | -69.2% | -166.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.